Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Overview of attention for article published in JAMA Ophthalmology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 4,526)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 55 news outlets
blogs: 3 blogs
twitter: 38 X users
reddit: 3 Redditors

video: 1 YouTube creator
guideline: 1 clinical guideline source
podcasts: 6 podcasts

Readers on

mendeley: 93 Mendeley

So far, Altmetric has seen 43 X posts from 38 X users, with an upper bound of 139,255 followers.

RT @JAMAOphth: Most viewed in the last 7 days from @JAMAophth: Do low-dose atropine, 0.01%, eye drops delivered nightly over 2 years slow…

Most viewed in the last 7 days from @JAMAophth: Do low-dose atropine, 0.01%, eye drops delivered nightly over 2 years slow the progression of myopia in children aged 5 to 12 years in the US? https://t.co/S3xqRZn6II https://t.co/D3OKX9GkzT

RT @NEIDirector: Clinical trial results: low-dose atropine (0.01%) no better than placebo at slowing #myopia progression. This #NEIfunded…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 39 additional X posts.